4.4 Review

Role of Autophagy in Cancer Prevention

期刊

CANCER PREVENTION RESEARCH
卷 4, 期 7, 页码 973-983

出版社

AMER ASSOC CANCER RESEARCH
DOI: 10.1158/1940-6207.CAPR-10-0387

关键词

-

类别

资金

  1. Pfizer
  2. Johnson Johnson
  3. U.S. NIH [R37 CA53370, R01 CA130893, RC1 CA147961]
  4. New Jersey Commission on Cancer Research [09-1083-CCR-EO]
  5. U.S. Department of Defense [W81XWH06-1-0514, W81XWH05]

向作者/读者索取更多资源

Macroautophagy (autophagy hereafter) is a catabolic process by which cells degrade intracellular components in lysosomes. This cellular garbage disposal and intracellular recycling system maintains cellular homeostasis by eliminating superfluous or damaged proteins and organelles and invading microbes and by providing substrates for energy generation and biosynthesis in stress. Autophagy thus promotes the health of cells and animals and is critical for the development, differentiation, and maintenance of cell function and for the host defense against pathogens. Deregulation of autophagy is linked to susceptibility to various disorders including degenerative diseases, metabolic syndrome, aging, infectious diseases, and cancer. Autophagic activity emerges as a critical factor in the development and progression of diseases that are associated with increased cancer risk as well as in different stages of cancer. Given that cancer is a complex process and autophagy exerts its effects in multiple ways, the role of autophagy in tumorigenesis is context-dependent. As a cytoprotective survival pathway, autophagy prevents chronic tissue damage that can lead to cancer initiation and progression. In this setting, stimulation or restoration of autophagy may prevent cancer. In contrast, once cancer occurs, many cancer cells upregulate basal autophagy and utilize autophagy to enhance fitness and survive in the hostile tumor microenvironment. These findings revealed the concept that aggressive cancers can be addicted to autophagy for survival. In this setting, autophagy inhibition is a therapeutic strategy for established cancers. Cancer Prev Res; 4(7); 973-83. (C)2011 AACR.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据